In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Lanthio Pharma BV

Division of MorphoSys AG
www.lanthiopharma.com

Latest From Lanthio Pharma BV

MorphoSys CEO Says Strategy To Build Proprietary Pipeline 'On Track'

MorphoSys CEO Simon Moroney tells Scrip that sales of Tremfya in the US and now Europe as a treatment for plaque psoriasis will help fund the German biotech's nascent proprietary pipeline.

Approvals Companies

Dezima Pharma Raises $18.6 Million For Next-Generation CETP Inhibitor

Dutch start-up Dezima Pharma raises $18.6 million in Series A funding and government loans to move a next-generation CETP inhibitor to Phase III.

BioPharmaceutical Research and Development Strategies

Aileron Overcoming Spirited Debate About Stapled Peptides

The new, promising class of drugs is rolling toward the clinic, but a respected research group recently thrust a stick in the spokes and prompted a call for wider access to the technology.

BioPharmaceutical North America

With Dueling Papers Comes A Spirited Debate About Stapled Peptides

The new, promising class of drugs is rolling toward the clinic, but a respected research group recently thrust a stick in the spokes and prompted a call for wider access to the technology.

BioPharmaceutical North America
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • Molecular Diversity
    • Large Molecule
  • Pharmaceuticals
  • Therapeutic Areas
  • Musculoskeletal & Connective Tissue Disorders
  • Renal System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Benelux
          • Netherlands
  • Parent & Subsidiaries
  • MorphoSys AG
  • Senior Management
  • Heinz Schwer, PhD, MBA, CEO
    Gert Moll, PhD, CSO
    Sjoerd Wadman, VP, R&D
    Michiel Lodder, PhD, VP, Bus. Dev.
  • Contact Info
  • Lanthio Pharma BV
    Phone: 50 30 50 240
    P.O. Box 719 Groningen, 9700 AS
    Netherlands
Advertisement
Advertisement
UsernamePublicRestriction

Register